X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (69) 69
male (45) 45
index medicus (42) 42
adult (28) 28
female (28) 28
middle aged (28) 28
animals (23) 23
aged (22) 22
critical care medicine (20) 20
sepsis (17) 17
mortality (15) 15
rats (15) 15
analysis (13) 13
apoptosis (12) 12
rats, wistar (12) 12
risk factors (12) 12
treatment outcome (12) 12
urology & nephrology (12) 12
prognosis (11) 11
respiratory system (11) 11
critically ill (10) 10
health aspects (10) 10
oxygen consumption (10) 10
biochemistry & molecular biology (9) 9
critical illness - therapy (9) 9
liver - metabolism (9) 9
oxidative stress (9) 9
aged, 80 and over (8) 8
liver (8) 8
medicine, general & internal (8) 8
physiological aspects (8) 8
prospective studies (8) 8
survival (8) 8
care and treatment (7) 7
critical care (7) 7
critical illness - mortality (7) 7
diabetes (7) 7
disease (7) 7
failure (7) 7
further section (7) 7
gene-expression (7) 7
hospital mortality (7) 7
intensive care units (7) 7
oncology (7) 7
studies (7) 7
critical illness (6) 6
critically-ill patients (6) 6
expression (6) 6
glutathione (6) 6
insulin (6) 6
intensive care (6) 6
model (6) 6
outcomes (6) 6
oxygen - blood (6) 6
pharmacology & pharmacy (6) 6
research (6) 6
respiratory distress syndrome, adult - physiopathology (6) 6
risk (6) 6
severity of illness index (6) 6
ventilation (6) 6
abridged index medicus (5) 5
acute renal failure (5) 5
adolescent (5) 5
cancer (5) 5
cohort studies (5) 5
hemodynamics (5) 5
hyperglycemia (5) 5
liver - drug effects (5) 5
medical research (5) 5
nutrition & dietetics (5) 5
patients (5) 5
pediatrics (5) 5
respiration, artificial (5) 5
septic shock (5) 5
time factors (5) 5
abstracts (4) 4
acute kidney injury (4) 4
acute respiratory distress syndrome (4) 4
antioxidants (4) 4
cardiac output (4) 4
causes of (4) 4
cell biology (4) 4
cell hypoxia (4) 4
cells, cultured (4) 4
chemistry (4) 4
complications (4) 4
disease models, animal (4) 4
environmental sciences (4) 4
epidemiology (4) 4
glucose (4) 4
hepatocellular-carcinoma (4) 4
hepatocytes - metabolism (4) 4
hypoglycemic agents - therapeutic use (4) 4
inflammation (4) 4
inhibition (4) 4
insulin - therapeutic use (4) 4
lactic acid (4) 4
liver regeneration - physiology (4) 4
management (4) 4
metabolism (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Liver International, ISSN 1478-3223, 07/2019, Volume 39, Issue 7, pp. 1271 - 1280
Background and Aims Patients with acute‐on‐chronic liver failure (ACLF) have high mortality rates. Most prognostic scores were not developed for the intensive... 
critical care | death | prognosis | cirrhosis | SURVIVAL | SCORE | VALIDATION | RISK | MODEL | SEPSIS | DISEASE | CIRRHOTIC-PATIENTS | GASTROENTEROLOGY & HEPATOLOGY | CRITICALLY-ILL PATIENTS | Lactates | Medical research | Liver failure | Prognosis | Analysis | Mortality | Patient outcomes | Medicine, Experimental | Liver cirrhosis | Evaluation | Intensive care | Liver diseases | Liver | Calibration | Consortia | Training | Cirrhosis | Prediction models | Failure analysis | Lactic acid | Failure
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2009, Volume 360, Issue 13, pp. 1283 - 1297
Journal Article
Journal Article
by Rovin, Brad H and Caster, Dawn J and Cattran, Daniel C and Gibson, Keisha L and Hogan, Jonathan J and Moeller, Marcus J and Roccatello, Dario and Cheung, Michael and Wheeler, David C and Winkelmayer, Wolfgang C and Floege, Jürgen and Adler, Sharon G and Alpers, Charles E and Ayoub, Isabelle and Bagga, Arvind and Barbour, Sean J and Barratt, Jonathan and Chan, Daniel T.M and Chang, Anthony and Choo, Jason Chon Jun and Cook, H. Terence and Coppo, Rosanna and Fervenza, Fernando C and Fogo, Agnes B and Fox, Jonathan G and Glassock, Richard J and Harris, David and Hodson, Elisabeth M and Hogan, Jonathan J and Hoxha, Elion and Iseki, Kunitoshi and Jennette, J. Charles and Jha, Vivekanand and Johnson, David W and Kaname, Shinya and Katafuchi, Ritsuko and Kitching, A. Richard and Lafayette, Richard A and Li, Philip K.T and Liew, Adrian and Lv, Jicheng and Malvar, Ana and Maruyama, Shoichi and Mejía-Vilet, Juan Manuel and Mok, Chi Chiu and Nachman, Patrick H and Nester, Carla M and Noiri, Eisei and O'Shaughnessy, Michelle M and Özen, Seza and Parikh, Samir M and Park, Hyeong-Cheon and Peh, Chen Au and Pendergraft, William F and Pickering, Matthew C and Pillebout, Evangéline and Radhakrishnan, Jai and Rathi, Manish and Ronco, Pierre and Smoyer, William E and Tang, Sydney C.W and Tesař, Vladimír and Thurman, Joshua M and Trimarchi, Hernán and Vivarelli, Marina and Walters, Giles D and Wang, Angela Yee-Moon and Wenderfer, Scott E and Wetzels, Jack F.M and Conference Participants and Conf Participants
Kidney International, ISSN 0085-2538, 02/2019, Volume 95, Issue 2, pp. 281 - 295
In November 2017, the Kidney Disease: Improving Global Outcomes (KDIGO) initiative brought a diverse panel of experts in glomerular diseases together to... 
monoclonal gammopathies of renal significance | membranoproliferative glomerulonephritis | C3 glomerulopathy | KDIGO | lupus nephritis | anti-neutrophil cytoplasmic antibody–associated vasculitis | minimal change disease | focal and segmental glomerulosclerosis | CLINICS CLASSIFICATION CRITERIA | SYSTEMIC-LUPUS-ERYTHEMATOSUS | HEMOLYTIC-UREMIC SYNDROME | THROMBOTIC MICROANGIOPATHY | UROLOGY & NEPHROLOGY | ANCA-ASSOCIATED VASCULITIS | anti-neutrophil cytoplasmic antibody-associated vasculitis | IDIOPATHIC NEPHROTIC SYNDROME | B MEMBER 9 | FOCAL SEGMENTAL GLOMERULOSCLEROSIS | CHAIN DEPOSITION DISEASE | STAGE RENAL-DISEASE | Glomerulonephritis - therapy | Genetic Testing | Humans | Paraproteinemias - genetics | Nephrology - standards | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - diagnosis | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - complications | Nephrology - methods | Glomerulonephritis - etiology | Nephrosis, Lipoid - etiology | Glomerular Filtration Rate | Paraproteinemias - diagnosis | Risk Factors | Biomarkers - analysis | Treatment Outcome | Nephrosis, Lipoid - therapy | Paraproteinemias - complications | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - genetics | Podocytes - pathology | Consensus Development Conferences as Topic | Disease Progression | Nephrosis, Lipoid - pathology | Glomerulonephritis - pathology | Podocytes - immunology | Practice Guidelines as Topic | Life Sciences | Biochemistry, Molecular Biology | Genomics
Journal Article
Kidney International, ISSN 0085-2538, 02/2019, Volume 95, Issue 2, pp. 268 - 280
Journal Article
Journal Article
Journal Article
Annals of Oncology, ISSN 0923-7534, 11/2014, Volume 25, Issue 11, pp. 2147 - 2155
We conducted two nonindustry biomarker-directed randomized clinical trials in advanced non-small-cell lung cancer, comparing nonselected cisplatin-based... 
clinical trial | customized chemotherapy | BRCA1 | RAP80 | biomarkers | non-small-cell lung cancer | MESSENGER-RNA EXPRESSION | DNA-DAMAGE RESPONSE | DOCETAXEL | CHEMOTHERAPY | PHASE-III TRIAL | REPAIR | BRCA1 FUNCTIONS | CISPLATIN | ONCOLOGY | MOUSE MODEL | HOMOLOGOUS RECOMBINATION |